Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | Milano | Salute | Prodotti farmaceutici | 265,59 Mrd € | 21,5x | -1,15 | 103,80 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sanofi S.A. | Milano | Salute | Prodotti farmaceutici | 125,01 Mrd € | 13,7x | -0,58 | 99,05 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Gilead Sciences | Milano | Salute | Prodotti farmaceutici | 84,95 Mrd € | 89,5x | -1,08 | 68,20 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Milano | Salute | Prodotti farmaceutici | 74,11 Mrd € | 28,2x | -1,87 | 169,95 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bayer AG | Milano | Salute | Prodotti farmaceutici | 27,44 Mrd € | -21,5x | 0,12 | 27,95 € | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Recordati | Milano | Salute | Prodotti farmaceutici | 10,55 Mrd € | 27,4x | -69,98 | 51,45 € | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,1% Rialzo | Fai l’upgrade a Pro+ | |
Pharmanutra | Milano | Salute | Prodotti farmaceutici | 486,52 Mln € | 44,8x | -1,31 | 50,50 € | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 59% Rialzo | Fai l’upgrade a Pro+ | |
Shedir Pharma | Milano | Salute | Prodotti farmaceutici | 45,22 Mln € | 8,1x | -1,55 | 3,98 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 103% Rialzo | Fai l’upgrade a Pro+ | |
Laboratorio Farmaceutico Erfo | Milano | Salute | Prodotti farmaceutici | 9,33 Mln € | 17,6x | -1,22 | 1,09 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,9% Rialzo | Fai l’upgrade a Pro+ | |
Friulchem | Milano | Salute | Prodotti farmaceutici | 4,95 Mln € | 167,9x | 0,83 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 44,6% Rialzo | Fai l’upgrade a Pro+ |